Author: Gruber, Conor; Patel, Roosheel S.; Trachtman, Rebecca; Lepow, Lauren; Amanat, Fatima; Krammer, Florian; Wilson, Karen M.; Onel, Kenan; Geanon, Daniel; Tuballes, Kevin; Patel, Manishkumar; Mouskas, Konstantinos; O'Donnell, Timothy; Merritt, Elliot; Simons, Nicole; Barcessat, Vanessa; Del Valle, Diane M.; Udondem, Samantha; Kang, Gurpawan; Gangadharan, Sandeep; Ofori-Amanfo, George; Laserson, Uri; Rahman, Adeeb; Kim-Schulze, Seunghee; Charney, Alexander; Gnjatic, Sacha; Gelb, Bruce D.; Merad, Miriam; Bogunovic, Dusan
Title: Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) Cord-id: y1ob8tcq Document date: 2020_9_14
ID: y1ob8tcq
Snippet: Initially, children were thought to be spared from disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, a month into the epidemic, a novel multisystem inflammatory syndrome in children (MIS-C) emerged. Herein, we report on the immune profiles of nine MIS-C cases. All MIS-C patients had evidence of prior SARS-CoV-2 exposure, mounting an antibody response with intact neutralization capability. Cytokine profiling identified elevated signatures of inflammation (IL
Document: Initially, children were thought to be spared from disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, a month into the epidemic, a novel multisystem inflammatory syndrome in children (MIS-C) emerged. Herein, we report on the immune profiles of nine MIS-C cases. All MIS-C patients had evidence of prior SARS-CoV-2 exposure, mounting an antibody response with intact neutralization capability. Cytokine profiling identified elevated signatures of inflammation (IL-18 and IL-6), lymphocytic and myeloid chemotaxis and activation (CCL3, CCL4, and CDCP1) and mucosal immune dysregulation (IL-17A, CCL20, CCL28). Immunophenotyping of peripheral blood revealed reductions of non-classical monocytes, and subsets of NK- and T- lymphocytes, suggesting extravasation to affected tissues. Finally, we profiled the auto-antigen reactivity of MIS-C plasma, which revealed both known disease-associated autoantibodies (anti-La) and novel candidates that recognize endothelial, gastrointestinal and immune-cell antigens. All patients were treated with anti-IL6R antibody and/or IVIG, which led to rapid disease resolution.
Search related documents:
Co phrase search for related documents- acute infection and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute infection and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
- acute infection and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute infection and admission test: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute infection and live sars infection: 1
- acute infection and local sars transmission: 1, 2, 3, 4
- acute infection and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- acute infection and lymphocyte activation: 1, 2, 3, 4, 5, 6, 7, 8, 9
- adaptive immunity and low prevalence: 1, 2
- adaptive immunity and lymphocyte activation: 1, 2, 3, 4, 5, 6, 7
- adaptive innate and admission day: 1
- adaptive innate and live sars infection: 1
- adaptive innate and lymphocyte activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- admission prior and low prevalence: 1, 2
- admission test and low prevalence: 1
Co phrase search for related documents, hyperlinks ordered by date